Dihydrocodeine / guaifenesin / pseudoephedrine Drug Interactions
A total of 1058 drugs are known to interact with dihydrocodeine / guaifenesin / pseudoephedrine.
- 306 major drug interactions
- 737 moderate drug interactions
- 15 minor drug interactions
Check for interactions
Most frequently checked interactions
View interaction reports for dihydrocodeine / guaifenesin / pseudoephedrine and the medicines listed below.
- Aspirin Low Strength (aspirin)
- Betnovate (betamethasone topical)
- Cialis (tadalafil)
- CoQ10 (ubiquinone)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Glucophage (metformin)
- Glucovance (glyburide / metformin)
- Lyrica (pregabalin)
- Morphine Sulfate ER (morphine)
- Morphine Sulfate SR (morphine)
- Naprosyn (naproxen)
- Nitrolingual Pumpspray (nitroglycerin)
- Oramorph SR (morphine)
- Paracetamol (acetaminophen)
- Sporanox (itraconazole)
- Super B Complex (multivitamin)
- Tramadol Hydrochloride ER (tramadol)
- Vitamin B Complex 100 (multivitamin)
- Vitamin D3 (cholecalciferol)
- Voltaren Gel (diclofenac topical)
Dihydrocodeine / guaifenesin / pseudoephedrine alcohol/food interactions
There is 1 alcohol/food interaction with dihydrocodeine / guaifenesin / pseudoephedrine
Dihydrocodeine / guaifenesin / pseudoephedrine disease interactions
There are 22 disease interactions with dihydrocodeine / guaifenesin / pseudoephedrine which include:
- impaired GI motility
- infectious diarrhea
- liver disease
- prematurity
- renal dysfunction
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- cardiovascular disease
- adrenal insufficiency
- biliary spasm
- hypothyroidism
- seizure disorders
- urinary retention
- arrhythmias
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
